BioElectronics in the news, Again!

BioElectronics has been all over the FNP lately. That’s because they have a great product!

From Today’s FNP:

Frederick-based BioElectronics Corp. is one of 18 firms to receive a combined $4.4 million for new collaborative research projects between Maryland companies and University of Maryland faculty.

BioElectronics makes ActiPatch, a drug-free, anti-inflammatory patch that reduces swelling. The company, located at 4539 Metropolitan Court, was awarded $258,788 from the University of Maryland Industrial Partnerships Program. The money will fund oral surgery research, beginning in March.

BioElectronics develops and markets ActiPatch medical devices that deliver pulsed electromagnetic frequency therapies that accelerate healing in soft-tissue injuries.

I started an experiment this week using the ActiPatch to determine if this has an effect on my amniotic hu-MSC’s in vitro.  I had a couple of available conditions in my plate, so I decided to throw a T-25 flask sitting on an Actipatch in during the differentiation cycle to see what happens.  My objective is to determine the potential of the cells o differentiate into neurons, as previous studies have shown a significat population of neuronal precursors.
Although I don’t have any evidence, I would theorize that the ActiPatch may be playing some role in stem cell trafficing related to wound healing.  There is an ambiguous connection between the CNS and immune response, which is  an element of wound healing.  I think it will be interesting to see.

I can tell that after 5 days in culture, there are some marked morphological differences between my ActiPatch culture, the control plate and other conditions.  Should know more by the end of the month.